We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+6.78%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$20.9B
AUM Growth
+$2.5B
Cap. Flow
+$1.34B
Cap. Flow %
6.41%
Top 10 Hldgs %
19.15%
Holding
3,219
New
357
Increased
1,640
Reduced
999
Closed
136

Sector Composition

Rank Sector Weight
1 Technology 9.32%
2 Consumer Discretionary 5.02%
3 Financials 4.84%
4 Healthcare 4.11%
5 Communication Services 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSS
3026
DELISTED
Golden Star Resources Ltd.
GSS
$50K ﹤0.01%
17,719
+1,956
+12% +$6.54K
IPOD.WS
3027
DELISTED
Social Capital Hedosophia Holdings Corp. IV Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
IPOD.WS
$49K ﹤0.01%
20,000
+6,000
+43% +$13.6K
PHX
3028
DELISTED
PHX Minerals
PHX
$48K ﹤0.01%
12,997
+787
+6% +$2.39K
GSAT icon
3029
Globalstar
GSAT
$10.8B
$45K ﹤0.01%
1,688
-234
-12% -$4.59K
OGI
3030
Organigram Holdings
OGI
$170M
$45K ﹤0.01%
3,949
-178
-4% -$2.03K
SUPV
3031
Grupo Supervielle
SUPV
$733M
$41K ﹤0.01%
20,000
CENN icon
3032
Cenntro
CENN
$8.36M
$39K ﹤0.01%
7
PLG
3033
Platinum Group Metals
PLG
$201M
$39K ﹤0.01%
10,804
-5,000
-32% -$21.4K
WMC
3034
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$39K ﹤0.01%
1,205
-145
-11% -$4.8K
THER
3035
DELISTED
THERATECHNOLOGIES INC COM
THER
$39K ﹤0.01%
10,130
-2,000
-16% -$7.7K
NERV icon
3036
Minerva Neurosciences
NERV
$205M
$36K ﹤0.01%
1,925
-188
-9% -$4.05K
DXYN
3037
DELISTED
Dixie Group Inc
DXYN
$36K ﹤0.01%
12,310
+2,310
+23% +$7.12K
VERO
3038
DELISTED
Venus Concept
VERO
$35K ﹤0.01%
68
CFMS
3039
DELISTED
Conformis, Inc. Common Stock
CFMS
$35K ﹤0.01%
+1,221
New +$28.8K
AVTX icon
3040
Avalo Therapeutics
AVTX
$1.05B
$34K ﹤0.01%
+4
New +$33.5K
NXTP
3041
DELISTED
NextPlay Technologies, Inc. Common Stock
NXTP
$34K ﹤0.01%
+750
New +$39.6K
SMTS
3042
DELISTED
Sierra Metals Inc. Common Stock
SMTS
$34K ﹤0.01%
+11,365
New +$37.6K
TLPH icon
3043
Talphera
TLPH
$71.6M
$33K ﹤0.01%
1,209
GORO icon
3044
Goldgroup Mining Inc.
GORO
$203M
$32K ﹤0.01%
12,488
+51
+0.4% +$141
BCIC
3045
BCP Investment Corp
BCIC
$95.4M
$31K ﹤0.01%
+1,287
New +$30.5K
IDEX
3046
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$30K ﹤0.01%
+85
New +$30.3K
CPIX icon
3047
Cumberland Pharmaceuticals
CPIX
$120M
$28K ﹤0.01%
10,000
NBEV
3048
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$28K ﹤0.01%
12,515
+270
+2% +$629
HNRG icon
3049
Hallador Energy
HNRG
$747M
$27K ﹤0.01%
+10,200
New +$24.1K
CCO icon
3050
Clear Channel Outdoor Holdings
CCO
$1.23B
$26K ﹤0.01%
10,000
-4,400
-31% -$10.6K

Similar funds

Cambridge Investment Research Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Cambridge Investment Research Advisors held 3,219 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Cambridge Investment Research Advisors deployed $1.34B of net new capital in Q2 2021, opening 357 new positions and adding to 1,640 existing holdings. Its largest new stake was Vanguard Morningstar Growth ETF: 2,637,318 shares worth $126M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, up from 8.9% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Vanguard Short-Term Treasury ETF, an estimated $17.7M trimmed.

  • Cambridge Investment Research Advisors's largest Q2 2021 buy was Vanguard Morningstar Growth ETF: 2,637,318 shares worth $126M.
  • Cambridge Investment Research Advisors added most to FS KKR Capital in Q2 2021, an estimated $36M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2021 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $17.7M.
  • Cambridge Investment Research Advisors fully exited Teucrium Corn Fund in Q2 2021, selling an estimated $4.14M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 19% of its $20.9B portfolio in Q2 2021.
  • Cambridge Investment Research Advisors opened 357 new positions and closed 136 in Q2 2021.
  • Cambridge Investment Research Advisors's portfolio value rose 14% quarter-over-quarter to $20.9B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2021, filed 10 Aug 2021.